These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22825665)

  • 21. Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale.
    Jayanti A; Wearden AJ; Morris J; Brenchley P; Abma I; Bayer S; Barlow J; Mitra S
    BMC Nephrol; 2013 Sep; 14():197. PubMed ID: 24044499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Home haemodialysis.
    Hothi DK; Stronach L; Harvey E
    Pediatr Nephrol; 2013 May; 28(5):721-30. PubMed ID: 23124511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing a home haemodialysis programme without adversely affecting a peritoneal dialysis programme.
    Copland M; Murphy-Burke D; Levin A; Singh RS; Taylor P; Er L
    Nephrol Dial Transplant; 2009 Aug; 24(8):2546-50. PubMed ID: 19329791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staff-assisted home hemodialysis in debilitated or terminally ill patients.
    Agraharkar M; Barclay C; Agraharkar A
    Int Urol Nephrol; 2002; 33(1):139-44. PubMed ID: 12090321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Debate: Should dialysis at home be mandatory for all suitable ESRD patients?: home-based dialysis therapies are the second choice after transplantation.
    Lewicki MC; Polkinghorne KR; Kerr PG
    Semin Dial; 2015; 28(2):147-54. PubMed ID: 25481976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home haemodialysis: Providing opportunities to reimagine haemodialysis care.
    Mitra S; Kharbanda K; Ebah L
    Nephrol Ther; 2021 Apr; 17S():S60-S63. PubMed ID: 33910700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home haemodialysis-international trends and variation.
    MacGregor MS; Agar JW; Blagg CR
    Nephrol Dial Transplant; 2006 Jul; 21(7):1934-45. PubMed ID: 16537659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in patients on home haemodialysis in England and Wales, 1997-2005: a comparative cohort analysis.
    Nitsch D; Steenkamp R; Tomson CR; Roderick P; Ansell D; MacGregor MS
    Nephrol Dial Transplant; 2011 May; 26(5):1670-7. PubMed ID: 20841489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE; Ashton T
    N Z Med J; 1990 Apr; 103(888):171-4. PubMed ID: 2109846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going Home: Access for Home Modalities.
    Gardezi AI; Sequeira A; Narayan R
    Adv Chronic Kidney Dis; 2020 May; 27(3):253-262. PubMed ID: 32891310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patient perspective on the barriers to home dialysis.
    Hope J
    J Ren Care; 2013 Jan; 39 Suppl 1():3-8. PubMed ID: 23464907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost of starting and maintaining a large home hemodialysis program.
    Komenda P; Copland M; Makwana J; Djurdjev O; Sood MM; Levin A
    Kidney Int; 2010 Jun; 77(11):1039-45. PubMed ID: 20375983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal haemodialysis: an Australian cost comparison with conventional satellite haemodialysis.
    Agar JW; Knight RJ; Simmonds RE; Boddington JM; Waldron CM; Somerville CA
    Nephrology (Carlton); 2005 Dec; 10(6):557-70. PubMed ID: 16354238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure.
    Mowatt G; Vale L; Perez J; Wyness L; Fraser C; MacLeod A; Daly C; Stearns SC
    Health Technol Assess; 2003; 7(2):1-174. PubMed ID: 12773260
    [No Abstract]   [Full Text] [Related]  

  • 38. Nocturnal home haemodialysis: The 17 years experience of a single Australian dialysis service.
    Choo SZ; See EJ; Simmonds RE; Somerville CA; Agar JWM
    Nephrology (Carlton); 2019 Oct; 24(10):1050-1055. PubMed ID: 30393900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodialysis: hospital or home?
    Power A; Ashby D
    Postgrad Med J; 2014 Feb; 90(1060):92-7. PubMed ID: 24222691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.